Nuclear Receptors and Cancer Research: Current Trends and Applications
Nuclear receptors have long been a focus in cancer research. The role of dysregulated nuclear receptor mediated signaling pathways in tumorigenesis has been well documented in a variety of cancers. This makes nuclear receptors important therapeutic targets for identifying new therapies to combat cancer.
In this webinar, learn about cutting edge research from distinguished professors from Penn State University as they talk about the role of specific nuclear receptors in cancer, including:
- Aryl Hydrocarbon Receptor (AhR)
- Farnesoid X Receptor (FXR)
- Peroxisome Proliferator-Activated Receptors (PPARα, PPARδ and PPARγ)